Presents news briefs related to actions of the U.S. Food and Drug Administration on various pharmaceutical products. Approval of a surfactant product for neonatal respiratory distress syndrome therapy; Order to stop the distribution of Cal-Ban 3000 diet tablets and capsules.
No Comments.